Harmony Biosciences Holdings, Inc. (HRMY)
NASDAQ: HRMY · Real-Time Price · USD
38.41
-0.34 (-0.88%)
Aug 7, 2026, 4:00 PM EDT - Market closed
Harmony Biosciences Holdings Employees
Harmony Biosciences Holdings had 293 employees as of December 31, 2025. The number of employees increased by 25 or 9.33% compared to the previous year.
Employees
293
Change (1Y)
25
Growth (1Y)
9.33%
Revenue / Employee
$3,276,102
Profits / Employee
$618,669
Market Cap
2.24B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 293 | 25 | 9.33% |
| Dec 31, 2024 | 268 | 22 | 8.94% |
| Dec 31, 2023 | 246 | 46 | 23.00% |
| Dec 31, 2022 | 200 | 20 | 11.11% |
| Dec 31, 2021 | 180 | 30 | 20.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| ADMA Biologics | 647 |
| Vericel | 398 |
| Vera Therapeutics | 339 |
| Nuvation Bio | 307 |
| UroGen Pharma | 298 |
| Biohaven | 274 |
| Rapport Therapeutics | 84 |
| Sionna Therapeutics | 59 |
HRMY News
- 3 days ago - Harmony Biosciences to Participate in Piper Sandler Virtual CNS Symposium - GlobeNewsWire
- 4 days ago - Harmony Biosciences price target raised to $34 from $29 at Truist - TheFly
- 4 days ago - Harmony Biosciences price target raised to $39 from $36 at Deutsche Bank - TheFly
- 4 days ago - Harmony Biosciences price target raised to $37 from $33 at UBS - TheFly
- 4 days ago - Harmony Biosciences price target raised to $30 from $28 at BofA - TheFly
- 5 days ago - Harmony Biosciences Holdings Earnings Call Transcript: Q2 2026 - Transcripts
- 5 days ago - Harmony Biosciences Holdings Earnings release: Q2 2026 - Filings
- 5 days ago - Harmony Biosciences Holdings Slides: Q2 2026 - Filings